Envestnet Portfolio Solutions’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-803
Closed -$451K 1422
2025
Q4
$451K Sell
803
-226
-22% -$128K ﹤0.01% 1104
2025
Q3
$529K Sell
1,029
-929
-47% -$406K ﹤0.01% 1002
2025
Q2
$615K Sell
1,958
-551
-22% -$165K ﹤0.01% 997
2025
Q1
$765K Sell
2,509
-455
-15% -$153K ﹤0.01% 885
2024
Q4
$985K Sell
2,964
-86
-3% -$29.2K ﹤0.01% 933
2024
Q3
$1.02M Sell
3,050
-153
-5% -$58.1K ﹤0.01% 887
2024
Q2
$1.32M Sell
3,203
-368
-10% -$146K ﹤0.01% 772
2024
Q1
$1.44M Sell
3,571
-439
-11% -$154K 0.01% 730
2023
Q4
$1.23M Buy
4,010
+233
+6% +$62.9K 0.01% 737
2023
Q3
$915K Buy
+3,777
New +$966K ﹤0.01% 768

Other funds holding MEDP

Envestnet Portfolio Solutions's MEDP Position: Q1 2026 in Review

Envestnet Portfolio Solutions sold out of Medpace (MEDP) in Q1 2026, closing a stake of 803 shares — an estimated $451K sold.

Envestnet Portfolio Solutions first reported a position in MEDP in Q3 2023 and held it in 10 quarters. The position peaked at $1.44M in Q1 2024. 732 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Envestnet Portfolio Solutions reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 803 Medpace shares in Q1 2026, an estimated $451K.
  • Envestnet Portfolio Solutions first reported a position in Medpace in Q3 2023 and held it in 10 quarters.
  • Envestnet Portfolio Solutions's Medpace position peaked at $1.44M in Q1 2024.
  • 732 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q1 2026, filed 29 Apr 2026.